| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.00033 | 1 |